Companies: 10,795·Total market cap: $144.5T
Alto Neuroscience, Inc.

Alto Neuroscience, Inc.

ANRONYSEHealthcare● Active
$18.18
$-0.08(-0.44%)
Market Cap$638007829
P/E Ratio
52W High$28.441
52W Low$2.15

Alto Neuroscience, Inc.(ANRO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ANRO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)($0.00B)$0.00B($0.00B)$0.00B
Gross Margin %(computed)30.95%
Operating Expenses
R&D Expenses$0.05B$0.05B$0.03B$0.02B$0.01B
G&A Expenses$0.02B$0.02B$0.01B$0.01B$0.00B
Total Operating Expenses$0.07B$0.07B$0.04B$0.03B$0.01B
Operating Income($0.07B)($0.07B)($0.04B)($0.03B)($0.01B)
Operating Margin %(computed)
Interest Income$0.01B$0.01B$0.00B$0.00B$0.00B
Interest Expense$0.00B($0.00B)$0.00B$0.00B$0.00B
Income Before Tax($0.06B)($0.06B)($0.04B)($0.03B)($0.01B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.06B)($0.06B)($0.04B)($0.03B)($0.01B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.19$-2.50$-1.35$-1.08$-0.36
Wtd Avg Shares0.03B0.02B0.03B0.03B0.03B
EBITDA($0.07B)($0.07B)($0.03B)($0.03B)($0.01B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Alto Neuroscience, Inc.

关于Alto Neuroscience, Inc.(ANRO)损益表

Alto Neuroscience, Inc.(ANRO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ANRO实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.06B)(净利率—)。

常见问题

ANRO · 4 问

Alto Neuroscience, Inc.(ANRO)2025财年营收为$0.00B,同比down—%。

ANRO revenueANRO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08